Multiple endocrine neoplasia, type 1 (MEN 1)

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Areas that research this condition

Research

Mayo Clinic scientists are working to improve the diagnosis and treatment of multiple endocrine neoplasia, type 1 (MEN 1). Researchers study the treatment of recurrent parathyroid tumors with percutaneous ethanol ablation, better detection of uncommon carcinoid and neuroendocrine tumors, new chemotherapy drugs, and other interventional radiology ablative procedures.

Publications

See a list of publications about multiple endocrine neoplasia, type 1 (MEN 1) by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Edit search filters
close

Narrow your search

View all physicians • All Locations

By Mayo Clinic Staff

Multiple endocrine neoplasia, type 1 (MEN 1) care at Mayo Clinic

Request an appointment
Diagnosis & treatmentCare at Mayo Clinic
Feb. 14, 2024
Print

Related

Products & Services

Multiple endocrine neoplasia, type 1 (MEN 1)

Research: It's all about patients

[MUSIC PLAYING]

Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight.